Leaflet: Information for the user
Loperan 2 mg hard capsules
Loperamide, hydrochloride
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the leaflet
Loperan is an antidiarrheal that reduces intestinal movements and secretions, resulting in a decrease in liquid stools.
Loperan is indicated for the symptomatic treatment of acute nonspecific diarrhea in adults and children over 12 years of age.
Do not take Loperan
Warnings and precautions
Children and adolescents
Do not administer this medication to children under 12 years of age without medical prescription and supervision.
Taking Loperan with other medications
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
In particular, inform them if you are taking any of the following medications:
It may potentiate the action of drugs with similar properties.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
The safety of using loperamide during pregnancy has not been established, so it is advised not to use this medication without consulting your doctor first.
Breastfeeding
Women who are breastfeeding should not use this medication without consulting their doctor first, as small amounts of it may pass into breast milk.
Fertility
There is no data available on the possible effects of Loperan on fertility.
Driving and using machines
Drowsiness, dizziness, or somnolence may occur during treatment with Loperan. If these effects appear, it is advised not to use machines or drive vehicles.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Dosage
Adults
The recommended dose in adults is:
The maximum treatment duration will be 2 days.
Use in children and adolescents
The recommended dose in children over 12 years of age is:
Child's weight | Maximum number of capsules per day |
From 27 kg | Maximum 4 capsules |
From 34 kg | Maximum 5 capsules |
From 40 kg | Maximum 6 capsules |
From 47 kg | Maximum 7 capsules |
The maximum treatment duration will be 2 days.
Patient with liver disease
They should consult their doctor before taking this medication.
Method of administration:
This medication is administered orally.
Swallow the capsules with a sufficient amount of water.
If you take more Loperan than you should
If you have taken too much Loperan, contact a doctor or hospital for help as soon as possible, or a pharmacist or the Toxicology Information Service, phone 91.562.04.20, indicating the medication and the amount ingested.
Symptoms may include: increased heart rate, irregular heartbeats, cardiac arrhythmias (these symptoms can have potentially serious and life-threatening consequences), muscle stiffness, uncoordinated movements, somnolence, difficulty urinating, or weak breathing.
Children react more severely to high amounts of Loperan than adults. If a child takes an excessive amount or presents any of the above symptoms, call a doctor immediately.
In case of accidental ingestion, activated charcoal should be administered as soon as possible, followed by gastric lavage if vomiting has not occurred. Naloxone can be used as an antidote.
If you forget to take Loperan
Do not take a double dose to make up for forgotten doses.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not all people experience them.
Very common: at least 1 in 10 patients.
Common: at least 1 in 100 but less than 1 in 10 patients.
Uncommon: at least 1 in 1,000 but less than 1 in 100 patients.
Rare: at least 1 in 10,000 but less than 1 in 1,000 patients.
Very rare: at least 1 in 10,000 patients.
Frequency not known: cannot be estimated from available data.
The side effects described are:
Skin and subcutaneous tissue disorders:
Very rare: skin redness, itching, and/or skin swelling (exanthema, urticaria, and pruritus).
Frequency not known: sudden appearance of blisters on the skin (severe bullous reactions) such as Stevens-Johnson syndrome and toxic epidermal necrolysis.
Immune system disorders:
Frequency not known: severe allergic reactions (including anaphylactic shock), such as swelling of the lips, face, or tongue, and difficulty breathing.
Gastrointestinal disorders:
Various discomforts have been described that are normally difficult to distinguish from the symptoms associated with the diarrheal syndrome.
Very rare: dry mouth, abdominal pain, intestinal paralysis (no intestinal movements), abdominal distension, dilation of the large intestine (see Warnings and precautions), nausea, vomiting, flatulence, and dyspepsia (pain or unpleasant sensation in the upper-middle part of the stomach).
Frequency not known: upper abdominal pain, abdominal pain radiating to the back, abdominal tenderness, fever, rapid pulse, nausea, vomiting, which can be symptoms of pancreatitis (acute pancreatitis).
Renal and urinary disorders:
Frequency not known: urinary retention.
Psychiatric disorders:
Very rare: somnolence.
Nervous system disorders:
Very rare: loss of consciousness, decreased level of consciousness, dizziness, and fatigue.
If any of the following side effects occur, discontinue treatment and consult your doctor immediately:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Health Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Loperan composition
Appearance of the product and package contents
Loperan capsules are hard gelatin capsules, colored: white and green.
Loperan is available in packages containing 10 and 20 capsules.
Marketing authorization holder and manufacturer
Marketing authorization holder
CHIESI ESPAÑA, S.A.
Plaça d’Europa, 41-43, Planta 10
08908 L’Hospitalet de Llobregat
Barcelona (Spain)
Manufacturer
LABORATORIOS ALCALA FARMA S.L.U.
Avenida de Madrid, 82
28802 Alcalá de Henares (Madrid)
Date of the last revision of this leaflet: March 2022.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/